Stock Report

Download full stock data and analysis for free Last Updated: 06-Nov-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Cardiol Therapeutics Inc Class A (CRDL) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.93

up-down-arrow $-0.08 (-8.27%)

As on 05-Nov-2026 16:12EST

Market cap

info icon

$135 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

8.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 17.68 -6.87 -5.41 -30.60 -13.16
Net Profit 20.32 -3.45 -4.60 -29.72 -12.76
EPS 24.44 25.61 21.67 -1.51 8.15
Book Value -- -- -49.64 -33.31 -15.08
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info ---40,170.86------
Net Margin info ----------
Return on equity info -120.27-91.29-174.95-158.75-138.47
Return on Capital info -119.56-90.82---157.70-137.61
Return on Assets info -93.46-72.55-117.13-121.91-106.99
Debt to Equity (x) info ----0.000.010.01

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
-157.70
-137.61
-63.37
-39.71
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-174.95

Lower than Peers by 175.27

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
-174.95
-158.75
-138.47
-63.58
-39.77
Peer Median
0.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-117.13

Lower than Peers by 113.36

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
-117.13
-121.91
-106.99
-51.47
-34.15
Peer Median
-3.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
--
--
--
--
Peer Median
-28.91
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
--
--
--
--
Peer Median
-8.85
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
--
--
--
-1.00
Peer Median
10.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-5.41

Lower than Peers by 25.06

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
-5.41
7.79
-72.82
6.99
8.78
Peer Median
19.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-4.60

Lower than Peers by 64.77

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
-4.60
7.79
-72.82
6.99
8.78
Peer Median
60.17
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

21.67

Lower than Peers by 50.27

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
21.67
0.36
-0.62
0.09
0.19
Peer Median
71.94
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

46.41

Higher than Peers by 59.16

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
46.41
--
--
--
--
Peer Median
-12.75
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
0.01
0.01
0.01
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.00

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
0.00
0.00
0.00
0.00
0.00
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

5.55

Lower than Peers by 1.24

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
5.55
4.16
4.52
4.36
6.27
Peer Median
6.79
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

5.55

Lower than Peers by 1.37

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
5.55
--
--
4.39
--
Peer Median
6.93
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
--
--
--
--
Peer Median
0.84
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
--
--
--
--
Peer Median
22.62
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
--
--
--
--
Peer Median
0.15
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
--
--
-545.53
763.37
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
--
--
13,433.85
11,595.80
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Cardiol Therapeutics Inc Class A (CRDL)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds